These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1526 related items for PubMed ID: 32103760

  • 1. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
    Yang H, Zhang Q, Xu M, Wang L, Chen X, Feng Y, Li Y, Zhang X, Cui W, Jia X.
    Mol Cancer; 2020 Feb 27; 19(1):41. PubMed ID: 32103760
    [Abstract] [Full Text] [Related]

  • 2. LINC00330/CCL2 axis-mediated ESCC TAM reprogramming affects tumor progression.
    Zhao L, Wang G, Qi H, Yu L, Yin H, Sun R, Wang H, Zhu X, Yang A.
    Cell Mol Biol Lett; 2024 May 20; 29(1):77. PubMed ID: 38769475
    [Abstract] [Full Text] [Related]

  • 3. SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration.
    Wang C, Li Y, Wang L, Han Y, Gao X, Li T, Liu M, Dai L, Du R.
    Br J Cancer; 2024 May 20; 130(11):1770-1782. PubMed ID: 38600327
    [Abstract] [Full Text] [Related]

  • 4. Lysophosphatidic acid promotes ESCC progression by increasing the level of CCL2 secreted by esophageal epithelial cells.
    Ma H, Ma X, Qi L, Zhang Q, Wang T, Guo Q, Li P, Zhang S, Liu S.
    J Gene Med; 2024 Jun 20; 26(6):e3708. PubMed ID: 38837511
    [Abstract] [Full Text] [Related]

  • 5. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Li X, Yao W, Yuan Y, Chen P, Li B, Li J, Chu R, Song H, Xie D, Jiang X, Wang H.
    Gut; 2017 Jan 20; 66(1):157-167. PubMed ID: 26452628
    [Abstract] [Full Text] [Related]

  • 6. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Qu J, Zhao Q, Yang L, Ping Y, Zhang K, Lei Q, Liu F, Zhang Y.
    Int Immunopharmacol; 2021 Jul 20; 96():107616. PubMed ID: 34162127
    [Abstract] [Full Text] [Related]

  • 7. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
    Wang Y, Lyu Z, Qin Y, Wang X, Sun L, Zhang Y, Gong L, Wu S, Han S, Tang Y, Jia Y, Kwong DL, Kam N, Guan XY.
    Theranostics; 2020 Jul 20; 10(25):11535-11548. PubMed ID: 33052231
    [Abstract] [Full Text] [Related]

  • 8. TCF4 enhances hepatic metastasis of colorectal cancer by regulating tumor-associated macrophage via CCL2/CCR2 signaling.
    Tu W, Gong J, Zhou Z, Tian D, Wang Z.
    Cell Death Dis; 2021 Sep 27; 12(10):882. PubMed ID: 34580284
    [Abstract] [Full Text] [Related]

  • 9. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W, Tan F, Huai Q, Wang Z, Shao F, Zhang G, Yang Z, Li R, Xue Q, Gao S, He J.
    Front Immunol; 2021 Sep 27; 12():669750. PubMed ID: 34054840
    [Abstract] [Full Text] [Related]

  • 10. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
    Guo X, Zhu R, Luo A, Zhou H, Ding F, Yang H, Liu Z.
    J Exp Clin Cancer Res; 2020 Aug 31; 39(1):175. PubMed ID: 32867821
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of RCN1 inhibits esophageal squamous cell carcinoma progression and M2 macrophage polarization.
    Guo H, Shu J, Hu G, Liu B, Li J, Sun J, Wang X, Liu H, Xiong S, Tang Y, Yin Y, Wang X.
    PLoS One; 2024 Aug 31; 19(5):e0302780. PubMed ID: 38713738
    [Abstract] [Full Text] [Related]

  • 12. Key Genetic Determinants Driving Esophageal Squamous Cell Carcinoma Initiation and Immune Evasion.
    Ko KP, Huang Y, Zhang S, Zou G, Kim B, Zhang J, Jun S, Martin C, Dunbar KJ, Efe G, Rustgi AK, Nakagawa H, Park JI.
    Gastroenterology; 2023 Sep 31; 165(3):613-628.e20. PubMed ID: 37257519
    [Abstract] [Full Text] [Related]

  • 13. Tumor-associated macrophage polarization promotes the progression of esophageal carcinoma.
    Yuan X, Li Y, Zhang AZ, Jiang CH, Li FP, Xie YF, Li JF, Liang WH, Zhang HJ, Liu CX, Pang LJ, Shen XH, Li F, Hu JM.
    Aging (Albany NY); 2020 Dec 15; 13(2):2049-2072. PubMed ID: 33323552
    [Abstract] [Full Text] [Related]

  • 14. Homeobox A7 promotes esophageal squamous cell carcinoma progression through C-C motif chemokine ligand 2-mediated tumor-associated macrophage recruitment.
    Feng A, He L, Jiang J, Chu Y, Zhang Z, Fang K, Wang Z, Li Z, Sun M, Zhao Z, Shi J, Zhang L, Chen T, Xu M.
    Cancer Sci; 2023 Aug 15; 114(8):3270-3286. PubMed ID: 37248653
    [Abstract] [Full Text] [Related]

  • 15. Chemokine (C-C Motif) Ligand 1 Derived from Tumor-Associated Macrophages Contributes to Esophageal Squamous Cell Carcinoma Progression via CCR8-Mediated Akt/Proline-Rich Akt Substrate of 40 kDa/Mammalian Target of Rapamycin Pathway.
    Fujikawa M, Koma YI, Hosono M, Urakawa N, Tanigawa K, Shimizu M, Kodama T, Sakamoto H, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H.
    Am J Pathol; 2021 Apr 15; 191(4):686-703. PubMed ID: 33460563
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-33-nuclear factor-κB-CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells.
    Yue Y, Lian J, Wang T, Luo C, Yuan Y, Qin G, Zhang B, Zhang Y.
    Cancer Sci; 2020 Mar 15; 111(3):795-806. PubMed ID: 31883400
    [Abstract] [Full Text] [Related]

  • 17. MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway.
    Nan P, Wang T, Li C, Li H, Wang J, Zhang J, Dou N, Zhan Q, Ma F, Wang H, Qian H.
    Carcinogenesis; 2020 Sep 24; 41(9):1263-1272. PubMed ID: 31783401
    [Abstract] [Full Text] [Related]

  • 18. Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation.
    Li H, Miao Y, Zhong L, Feng S, Xu Y, Tang L, Wu C, Zhang X, Gu L, Diao H, Wang H, Wen Z, Yang M.
    Front Immunol; 2023 Sep 24; 14():1162032. PubMed ID: 37187751
    [Abstract] [Full Text] [Related]

  • 19. IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress.
    Liu Z, Gu S, Lu T, Wu K, Li L, Dong C, Zhou Y.
    J Exp Clin Cancer Res; 2020 Jul 29; 39(1):144. PubMed ID: 32727517
    [Abstract] [Full Text] [Related]

  • 20. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
    Yang C, Shen S, Zheng X, Ye K, Ge H, Sun Y, Lu Y.
    FASEB J; 2020 May 29; 34(5):6055-6069. PubMed ID: 32239565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 77.